The right choice should be based on the patients lab results, medical history, and prescriber instructions
Interestingly, there has been no reported toxicity associated with BPC-157, even at higher doses
Validating non-invasive biomarkers (e.g., urine exosomal ferroptosis-related proteins and circulating lipid peroxide metabolites) that reflect renal ferroptosis activity in DN patients is urgently needed for early diagnosis and therapeutic monitoring
Distinguished by its unique triple agonist mechanism, retatrutide targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors simultaneously
In terms of clinical outcomes , head-to-head trials have demonstrated efficacy differences between tirzepatide and selective GLP-1 receptor agonists